Stromal compartment as a survival prognostic factor in advanced ovarian carcinoma

International Journal of Gynecological Cancer

Volumn 20, Issue 1, 2010, Pages 28-33

  Labiche, Alexandre ^a   Heutte, Natacha ^a,b   Herlin, Paulette ^a   Chasle, Jacques ^a   Gauduchon, Pascal ^a   Elie, Nicolas ^a  

^a Centre Fran0ois Baclesse   (France)

^b UNIVERSITÉ DE CAEN   (France)

Author keywords

Ovarian carcinoma; Prognostic factor; Stroma; Virtual slide

Indexed keywords

CISPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HAZARD RATIO; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; LOG RANK TEST; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; OVERALL SURVIVAL; PARAMETER; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STROMA; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; STROMAL CELLS; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 74249107190     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181bda1cb     Document Type: Article

References (20)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
2. Wimberger P, Lehmann N, Kimmig R, et al. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol. 2007;106:69-74.
3. Ganss R. Tumor stroma fosters neovascularization by recruitment of progenitor cells into the tumor bed. J Cell Mol Med. 2006;10:857-865.
4. Suhonen KA, Anttila MA, Sillanpaa SM, et al. Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer. Eur J Cancer. 2007;43:1300-1307.
5. Goswami B, Rajappa M, Sharma M, et al. Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies. Int J Gynecol Cancer. 2007;18:591-599.
6. Anttila MA, Tammi RH, Tammi MI, et al. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res. 2000;60:150-155.
7. Elie N, Labiche A, Michels JJ, et al. Control of low-resolution scanning of ovarian tumor stromal compartment. Image Anal Stereol. 2005;24:85-93.
8. Calvet L, Geoerger B, Regairaz M, et al. Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecan. Oncogene. 2006;25: 3150-3159.
9. Schipper NW, Baak JP, Smeulders AW. Automated selection of the most epithelium-rich areas in gynecologic tumor sections. Anal Quant Cytol Histol. 1991;13:395-402.
10. Galaup A, Cazes A, Le Jan S, et al. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci U S A. 2006;103:18721-18726.
11. Dromain C, Balleyguier C, Muller S, et al. Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography. AJR Am J Roentgenol. 2006; 187:W528-W537.
12. Schipper NW, Smeulders AW, Baak JP. Evaluation of automated estimation of epithelial volume and its prognostic value in ovarian tumors. Lab Invest. 1989;61:228-234.
13. Brinkhuis M, Scheepstra C, Buist MR, et al. Intratumor heterogeneity of morphometric and stereologic variables in primary ovarian tumors and their omental metastatic deposits. Anal Quant Cytol Histol. 1997;19:185-193.
14. Athavale R, Thomakos N, Godfrey K, et al. The effect of epithelial and stromal tumor components on FIGO stages III and IV ovarian carcinosarcomas treated with primary surgery and chemotherapy. Int J Gynecol Cancer. 2007;17:1025-1030.
15. Robert M, Costa P, Bressolle F, et al. Percentage area density of epithelial and mesenchymal components in benign prostatic hyperplasia: comparison of results between single biopsy, multiple biopsies and multiple tissue specimens. Br J Urol. 1995;75:317-324.
16. Ueno H, Jones AM, Wilkinson KH, et al. Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut. 2004;53:581-586.
17. Schurch W, Lagace R, Seemayer TA. Myofibroblastic stromal reaction in retracted scirrhous carcinoma of the breast. Surg Gynecol Obstet. 1982;154:351-358.
18. Shimosato Y, Suzuki A, Hashimoto T, et al. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol. 1980;4:365-373.
19. Chi DS, Liao JB, Leon LF, et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol. 2001;82:532-537.
20. Winter WE 3rd, Maxwell GL, Tian C, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:3621-3627.